The National Aspergillosis Centre is part of the Manchester Fungal Infection Group (MFIG) who have just published an important paper in the very prestigious Nature Communications journal.
Sara Gago in Paul Bowyer’s lab has characterised a mutation carried by people that researchers have found make their airways stickier, thus enabling Aspergillus spores to stick and grow. The implications for infection (ABPA) are pretty clear and the group have already discovered that this mutation is common in people with ABPA (28% of patients in this study had this mutation). This leads us straight to thinking about screening out people who are prone to infection as they carry this gene mutation. We can then pay special attention to prevent them getting ABPA. What this means for people who already have ABPA is less clear, but certainly suggests another target for treatment.
Share this post
Latest News posts
John Guto: Chronic Pulmonary Aspergillosis
January 29, 2019
Tracking Adverse Medication Events and Drug:Drug Interactions
January 29, 2019
Breaking Thought Cycles Using Mindfulness
January 29, 2019
Prescribe Happiness to Improve Our Health
January 29, 2019
What Happens When Patients Lead the Health Team?
January 29, 2019
Getting a grip on pain and the brain: Prof Lorimer Moseley
January 29, 2019
All day in hospital
January 29, 2019
How to produce a sputum sample when asked
January 29, 2019
Meet e-Patient Dave: Take control of your illness management
January 29, 2019
What healthcare will look like in 2020: Patient communication
January 29, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video